A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389

Inclusion Criteria: For Hepatic: * Participant with a diagnosis of stable hepatic impairment For Healthy: * Participants who are overtly healthy as determined by medical evaluation including medical history, physical examination, and laboratory tests. All participants: \- Body weight ≥ 50 kg; BMI within the range of 18.0 to 42.0 kg/m2 (inclusive). Exclusion Criteria: * Participant has eGFR \< 60 mL/minute/1.73 m2 * Positive test for HIV at screening * History of severe allergy/hypersensitivity or ongoing clinically important allergy/hypersensitivity * History of severe dermatological disorders